Anti-NMDA Receptor Encephalitis Masquerades as Psychosis: A Case Report

Insights

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis can mimic psychosis. Early diagnosis through antibody testing and brain imaging is crucial for effective treatment and improved patient outcomes.

Area of Science:

  • Neurology
  • Immunology
  • Psychiatry

Background:

  • Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder that can present with neuropsychiatric symptoms.
  • Psychosis is a common presenting symptom, often leading to misdiagnosis and delayed treatment.

Observation:

  • A 28-year-old male presented with psychosis, agitation, and disorganized behavior, unresponsive to antipsychotic medications.
  • Brain MRI revealed diffuse hyperintensities; infectious, metabolic, and autoimmune workups were negative.
  • Positive NMDA receptor antibody tests in serum and cerebrospinal fluid confirmed the diagnosis.

Findings:

  • The patient's psychosis resolved following treatment with intravenous immunoglobulin and methylprednisolone.
  • This case highlights the importance of considering autoimmune encephalitis in unexplained psychosis, especially when accompanied by seizures.

Implications:

  • Early screening for NMDA receptor antibodies and brain imaging is vital for diagnosing anti-NMDA receptor encephalitis presenting as psychosis.
  • Comprehensive investigations to exclude other etiologies and prompt treatment (steroids, immunosuppressants, plasmapheresis, tumor removal if indicated) can significantly improve patient prognosis.

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
517
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.1K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
251
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
573
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
357
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
153